S.V. KHALIULLINA¹, G.S. SHAIKHIEVA², D.E. DOLOVSKOVA², O.G. DEMIDOVA², V.A. ANOKHIN¹

 ¹Kazan State Medical University, Kazan

²Prof. A.F. Agafonov Republican Clinical Infectious Diseases Hospital, Kazan

 Contact details:

Khaliullina S.V. — MD, Professor of the Department of Pediatric Infections

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7 (843)  267-80-06, e-mail: svekhal@mail.ru

Erythema infectiosum is the main clinical variant of infection associated with parvovirus B19 in children. Clinical symptoms include mild fever, erythema on the cheeks («a slapped face» symptom), and a maculopapular rash on the body that becomes lacy over time. But this characteristic of the rash is not always recorded. Parvovirus B19 is associated with various skin lesions that require a differential diagnosis with tick-borne borreliosis, sudden exanthema, hemorrhagic vasculitis, systemic lupus erythematosus, etc. The differential diagnosis is considered using the example of a 6-year-old child hospitalized in an Infectious Hospital with atypical manifestations of erythema infectiosum.

Key words: erythema infectiosum, parvovirus infection, parvovirus B19, children.

REFERENCES

1. Heegaard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev, 2002, vol. 15 (3), pp. 485–505. DOI: 10.1128/CMR.15.3.485-505.2002
2. de Cnc Garcia R., Leon L.A. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil. Future Microbiol, 2021, vol. 16 (1), pp. 37–50. DOI: 10.2217/fmb-2020-0123
3. Sim J.Y., Chang L.Y., Chen J.M., Lee P.I., Huang L.M., Lu C.Y. Human parvovirus B19 infection in patients with or without underlying diseases. J. Microbiol. Immunol. Inf, 2019, vol. 52 (4), pp. 534–541.
4. Chen A.Y., Qiu J. Parvovirus infection-induced cell death and cell cycle arrest. Future Virol, 2010, vol. 5 (6), pp. 731–743. DOI: 10.2217/fvl.10.56
5. Zakrzewska K., Arvia R., Bua G., Margheri F., Gallinella G. Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy. Asp. Mol. Med, 2023, vol. 1, p. 100007.
6. Söderlund‐Venermo M. Clinical significance of parvovirus B19 DNA in cutaneous biopsies. British J. Dermatol, 2017, vol. 177 (4), pp. 900–901. DOI: 10.1111/bjd.15811
7. Söderlund-Venermo M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet, 1997, vol. 349 (9058), pp. 1063–1065. DOI: 10.1016/S0140-6736(96)09110-6
8. Söderlund-Venermo M., Hokynar K., Nieminen J., Rautakorpi H., Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol. Biol. (Paris), 2002, vol. 50 (5), pp. 307–316. DOI: 10.1016/s0369-8114(02)00307-3
9. Kostolansky S., Waymack J.R. Erythema Infectiosum, 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. PMID: 30020681.
10. Magro C.M., Dawood M.R., Crowson A.N. The cutaneous manifestations of human parvovirus B19 infection. Hum. Pathol, 2000, vol. 31 (4), pp. 488–497. DOI: 10.1053/hp.2000.6714
11. Sève P., Ferry T., Koenig M., Cathebras P., Rousset H., Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin. Arthritis Rheum, 2005, vol. 34 (4), pp. 642–648. DOI: 10.1016/j.semarthrit.2004.07.008
12. Oura K., Ishikawa S., Shiraishi H., Maruo Y., Sato N., Suganuma T. et al. A One-year-old girl with human parvovirus B19 infection and hypocomplementemia mimicking incomplete Kawasaki disease. J. Med. Cases, 2022, vol. 13 (5), pp. 229–234. DOI: 10.14740/jmc3917